AU Patent

AU2008249772B2 — Novel piperazine salts as D3/D2 antagonists

Assigned to Richter Gedeon Nyrt · Expires 2013-09-05 · 13y expired

What this patent protects

The present invention relates to novel monohydrochloride, dihydrochloride, monohydrobromide, maleate and methanesulphonate salts of

USPTO Abstract

The present invention relates to novel monohydrochloride, dihydrochloride, monohydrobromide, maleate and methanesulphonate salts of

Drugs covered by this patent

cariprazine-hydrochloride (CARIPRAZINE HYDROCHLORIDE)

Patent Metadata

Patent number: AU2008249772B2
Jurisdiction: AU
Classification: —
Expires: 2013-09-05
Drug substance claim: No
Drug product claim: No
Assignee: Richter Gedeon Nyrt
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.